Aim: This study explores the degree of oxidative stress in essential arterial hypertension (EAH). Even oxidative stress appears as one of several metabolic abnormalities involved in essential hypertension, it remains uncertain whether is primary or secondary. However measurement of the main oxidant may be useful in order to recognize and monitor oxidative stress. Methods: Lipid peroxidation products (TBA reac tive substances) were determined in red blood cells (RBC) and serum together with markers of antioxidant status: total antioxidative capacity (AOC), catalase activity (CAT) and RBC glutathione (GSH) content in four investigated groups. The first group consisted of regularly and adequately treated hyper tensive patients without complication (regulated), patients with hyper tension and complication of some organs and organic systems were the non-regulated group. Third group were patients at the beginning of EAH (non-treated) and controls were normotensive individuals. Results: Compared with controls, regulated and non-treated group, non-regulated hyper tensive pati ents had higher TBARS concen tration in plasma (p<0.001) and lower AOC, CAT activity without differences in GSH content. Conclusion: Recent findings suggest that hyper tension is a condition followed by intensive oxidative stress and reduced antioxidant factors. Adequate and strictly controlled therapy, hygienic and diet regime and possible use of antioxidants can signi fi cantly reduce blood pressure and prevent possible complications.
Introduction
The main characteristic of arterial hypertension is a systolic pressure over 140 mm Hg and a diastolic pressure over 90 mm Hg. Epidemiological studies have shown that almost 25-30% of worldwide population suffer from this disease, mostly elderly persons (almost 50%), black population, patients suffering from renal diseases and diabetes. Possible etiological causes of hypertension are different, but in most cases they are unspe cified in terms of essential arterial hypertension (EAH). Data from "Framingham Heart Study" suggest that 78% of essential hypertension in men and 65% in women can be directly attributed to obesity and increased oxidative stress as the possible cause of compli ca tions that follow hypertension [1] . Oxidative stress occurs as a consequence of a disturbed balance between increased free radical production and insufficiency of antioxidant protection. Hypertension is a condition followed by intensive oxidative stress proven in the human population [2] and in experimental conditions [3] . Increased production of free radicals can be genetically caused because it has been proved that normotensive relatives of patients with hypertension have increased pro duction of hydrogen peroxide [4] .
The increased oxidative stress (OS) is the consequence of a higher adhesion molecule, P-selectine, and its expression and interaction between neutrophils and blood vessels walls which produce a great quantity of superoxide and hydrogen peroxide [5] . Increase of peripheral vascular resistance causes relative ischemia that, in respiratory chain, leads to electron "leaking" reaction with generation of superoxide anion radical. In such conditions activity of xanthine oxidase is elevated following an extra production of this radical. Disturbance of precise balance between NO, endothelin, angiotensine II and free radicals production causes hypertension as a consequence [6] .
Considering oxidative stress to be one of possible pathogenetic events involved in onset and development of essential hypertension, the purpose of this study was to examine intensity of lipid peroxidation, total antioxidative capacity, catalase activity and content of glutathione in red blood cells (RBC) and plasma of patients with EAH.
Materials and Methods
Patients were divided into four groups with 15 patients each. The first regularly treated group (regulated group) were the patients with blood pressure less than 149/90 mm Hg with individual therapy (Ca antagonists and ACE inhibitors mostly) without damage of target organs during 3 to 5 years. In the second group with hypertension during 3-5 years, (non regulated patients), the the rapy (Ca antagonists, ACE inhibitors and diuretics) was with out any effect and patients have complications of some organs and organic systems (hypertrophy of left ventriculy -12 patients and 3 patients with ischemic hypertensive nephropathy). In the third group were selected patients where hypertension was detected first time -the non treated group. Control group consisted of healthy volunteers of the same age as in other groups. The patients with diabetes mellitus, malignancy and other chronic diseases were excluded from the study. In control and investigated groups smokers and obese individuals were included. Blood pressure (BP) was measured before taking blood for biochemical analysis. BP was measured with a mercury sphygmomanometer, with the patient in the sitting position after 5 min of rest in a quiet environment, following the recommen dations of the British Hypertension Society. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were averaged by using two readings measured at 5-min intervals
Laboratory analysis
Biochemical parameters including triglycerides, cholesterol and HDL were deter mi ned on automated analyzer BioSystems A25 (Barcelona, Spain). LDL was calculated with Friedwald formula from triglycerides, total cholesterol and HDL cholesterol. The atherogenic index of plasma (AIP) was calculated as the log (triglycerides/HDL cholesterol) according to Dobiasova and Frohlich [7] .
Thiobarbituric acid reactive substances (TBARS) content, a measure of lipid peroxidation, was assayed in plasma and red blood cells according to the methods of Andreeva [8] and Jain [9] .
Total antioxidative capacity (AOC) was measured spectrophotometrically by the method of Koraćević et al. [10] and calculated from the formula:
A-absorbance of tested sample UA-absorbance of standard (uric acid) C UA -concentration of standard (mmol/l) The catalase activity was determined by the spectrophotometric method, based on the ability of hydrogen peroxide to form a stable stained complex with molybdenum salts [11] .
Improved method for the determination of blood reduced glutathione (GSH) was based on the formation of color product, monitored at 412 nm after adding of Ellman rea gent (5,5'-dithiobis-2-nitrobenzoic acid) [12] .
Statistical analysis
For statistical analysis, the Student's t-test and the Mann-Whitney Rank Sum test were used as appropriate. Differences were considered statistically different at p<0.05. Regression analysis was performed with the use of oxidative stress parameters (TBARS in plasma and RBC, catalase, GSH and AOC) as dependent variables and SBP and DBP as independent variables.
Results
The study was performed in 45 hypertensive subject and 15 control volunteers. The data of age and gender are summarized in Table 1 .
Among the hypertensive subjects and control no significant differences between groups in age and pole. Systolic and diastolic blood pressure were significantly higher in non-treated patients where hypertension was detected first time compared to control group (p<0.001) and hypertensive patients with regulated blood pressure (p<0.001). In the group of non regulated patients blood pressure was higher compared to con trol (systolic p<0.001, diastolic p<0.01) and patients with regulated hypertension and lower related to the non-treated group (Figure 1) .
Biochemical data of healthy and hypertensive subjects are presented in Table 2 . Trigly cerides were significantly higher in non regulated and non treated groups compared to the group with regulated hypertension (p<0.001, p<0.05, respectively) and control (p<0.001, p<0.01, respectively). There was also statistically difference for total cholesterol between groups. Total cholesterol was significantly higher in non regulated and non treated groups compared to group with regulated hypertension (p<0.001) and control (p<0.05; p<0.01, respectively). LDL was significantly higher in the group with non regulated hyper tension (4.49±1.22 mmol/l) compared to control (3.03±0.42 mmol/l; p<0.05). Index of athe rogenesis also was calculated and there was significant difference between groups. Group with non regulated hypertension and non treated hypertension had statistically higher index of atherogenesis compared to regulated hypertension group (p<0.001, p<0.05, respectively) and control (p<0.001; p<0.01, respectively). There was no significant difference between groups in HDL values.
Concentrations of TBARS in plasma were significantly higher in group with regulated hypertension, group with non treated hypertension and group with non regulated hyper tension compared to control (p<0.01; p<0.05; p<0.001, respectively) ( Figure 2) . Also, TBARS concentrations were significantly lower in groups with regulated hypertension and non trea ted hypertension compared to non regulated hypertension (p<0.001; p<0.01, respectively). Non-treated patients have higher concentrations of TBARS in RBC compared to the control (p<0.01) and regulated hypertension patients (p<0.01). A statistically significant correlation (r=0.521, p<0.01) was observed between TBARS levels in RBC and SBP (Figure 3) . Red blood level of TBARS also correlated significantly with DBP (r=0.561, p<0.01; Figure 4) . No significant correlation between another antioxidants and SBP and DBP was observed. Data for catalase activity, GSH concentrations and AOC, are showed in Table 3 . Cata lase activity was significantly lower in group with regulated hypertension (p<0.001), group with non treated patients (p<0.001) and group with non regulated hypertension (p<0.01) compared to control. AOC (%), were significantly lower in group with non regulated hyper tension and non treated hypertension compared to control (p<0.001; p<0.05, respec tively). Groups with regulated hypertension and non treated hypertension had sig nificantly higher AOC compared to non regulated hypertension (p<0.01). There was no statistically signi fi cance for GSH concentrations among groups.
Data are means ± SD. a -p < 0.001 vs. control; b -p < 0.01 vs. control; c -p < 0.001 vs. non treated; d -p < 0.001 vs. regulated

Discussion
Hypertension represents a powerful risk factor for cardiovascular disease (CVD) affecting millions worldwide. Their exact mechanisms are confounded by environmental factors and the presence of dyslipidemia, dysglycemia and insulin resistance that is often accompanied with essential hypertension [13] .
Patients with hypertension remain at increased risk of micro-and macrovascular complications unless their elevated blood pressure (BP) can be adequately controlled. The benefits of controlled BP are undisputed but epidemiological studies and randomised clinical trials have shown that, although treated, BP still remains inadequately controlled [14, 15] .
The results of this study demonstrate significant increase of total cholesterol and athero scle rosis index in a group with non regulated and non treted hypertension compared with control and group with regulated hypertension. Hypercholesterolemia and high levels of lowdensity lipoprotein (LDL) cholesterol result in impaired endothelial function in both peripheral and coronary circulation. Chole ste rol levels even in the normal range may be inversely related to endothelium-dependent vaso dilation that has important clinical implications [16] . The results of our study show increased level of LDL in a group with non regulated hypertension, but not in a group of non treated patients. These findings imply progression of atherosclerosis if hypertension remains uncontrolled.
Increased index of atherosclerosis in group with non treated hypertension, refers that decrease of vasodilatation ability of arterial wall, can be present in an early stages of hyper tension, and can be correlated with lower response to drug treatment [17, 18] .
Regardless on applied therapy the non regulated group have unregulated BP, lipid abnormalities as well as intensive oxidative stress. The possible explanation could be also find in association between certain clonidine. An emerging consensus from these studies is that single gene effects on antihypertensive drug responses are small, and even the combined effects of all presently known polymorphisms do not account for enough variation in response to be clinically useful [19] [20] [21] [22] . Endothelial dysfunction has been previously documented in patients with essential hyper tension [17, 18, 23] and, together with advanced atherosclerotic process, it could be the reason of lower drug effect within a group with non regulated hypertension.
Considering the numerous data about presence of oxidative stress in hyper ten sion, it remains unclear whether oxidative stress is the cause or consequence of hyperten sion. Hyper tension is joined with adhesion of leukocytes, accumulation of macrophages, migra tion and proliferation of smooth muscle cells into blood vessel intimae [24] . During these events a great quantity of free radicals is produced. The sources of free radicals can be also the kidney medulla -enzymes NADPH oxidase and mitochondrial enzymes, as well as xantin oxidase, activated as a response to a salt rich diet [25] . Our results show that if blood pressure is not drug and diet regulated a significant production of free radicals and intensive process of lipid peroxidation occur. These data are in accordance with study of Wen et al., [26] who also showed increase of TBARS concentration in plasma of patients with essential hypertension, and reduced concentration of vitamin C in plasma and vitamin E in erythrocytes. TBARS concentration in plasma of the group with regulated hypertension is significantly reduced related to the group of non regulated patients. Erythrocytes show statistically significant increase of TBARS concentra tions in the group with non regulated hypertension compared with the control group and the group with regulated hypertension.
Importance of free radicals in causing hypertension was proved in an experiment where tempol (mimetic SOD) and losartan (inhibitor of angio tensin receptor type 1), given to rats, block superoxide dismutase production and lower blood pressure [6] .
Total antioxidative capacity means active participation of different factors taking part in removal of free radicals. The obtained results show statistically significant decrease of AOC in the group with non regulated hypertension related to contol group and group with regulated hypertension. The data in group with non regulated hypertension, can be explained by increased production of free radicals [27] . Reduced catalase in all investigeted groups with hypertension indicate oxidative modification of this enzyme.
The decrease in catalase activity in our study may be attributed to its inactivation as a result of continuous exposure to hydroperoxides and hydrogen peroxide during oxidative stress [28] .
The genetic polymorphism of catalase could be associated with blood pressure levels. This poymorphism could influence catalse activity [29] . Alteration in oxidant-antioxidant status in essen tial hypertension also could lead to down-regulation of its expression [30] .
However, gluthation concentration remained unchanged in all groups.
Difference in ROS production between groups results from reduced effect of antihy pertensive drugs in group with nonregulated hyper tension. It has been reported that anti hyper tensive drugs, reduce production of ROS, which is confirmed in our and also in other studies [31] [32] [33] .
The obtained findings indicate that hypertension is a condition followed by intensive oxidative stress and reduced antioxidant factors. Adequate and strictly controlled therapy, hygienic and diet regime and possible use of antioxidants can signifi can tly reduce blood pressure and prevent possible complications.
